TY - JOUR
T1 - Treatment of thoracic aortic dissection with stent-grafts
T2 - Midterm results
AU - Shim, Won Heum
AU - Koo, Bon Kwon
AU - Yoon, Young sup
AU - Choi, Donghoon
AU - Jang, Yangsoo
AU - Lee, Do Yun
AU - Chang, Byoung chul
PY - 2002/12
Y1 - 2002/12
N2 - Purpose: To evaluate the early and midterm outcomes after stent-graft implantation for dissection in the descending thoracic aorta. Methods: Sixteen custom-made endovascular stent-grafts were implanted in 15 patients (10 men; mean age 55.9 ± 13.7 years, range 32-82) with descending thoracic aortic dissection. Indications for stent-graft implantation were persistent symptoms unresponsive to medical treatment or progressive enlargement of the false lumen. Clinical and imaging surveillance with computed tomography was performed within 1 month of the procedure and at 3 to 6-month intervals in follow-up. Results: Endovascular stent-graft implantation at the target site was successful in 14 (93%) patients; 1 device migrated, leaving the false lumen open to flow in the failed case. One (7%) patient who was treated emergently for rupture died suddenly 2 days after the procedure. Over an average follow-up of 31.5 ± 23.8 months, 1 (7%) patient died and 2 (14%) patients underwent surgical treatment due to recurrent dissection. The remaining 10 patients showed complete thrombosis of the false lumen; in 3, the false lumen completely resolved. Conclusions: Endovascular stent-graft implantation in descending thoracic aortic dissection is a feasible, safe, and effective treatment modality. However, further studies are necessary in a greater number of patients to determine if wider application of this minimally invasive procedure is justified.
AB - Purpose: To evaluate the early and midterm outcomes after stent-graft implantation for dissection in the descending thoracic aorta. Methods: Sixteen custom-made endovascular stent-grafts were implanted in 15 patients (10 men; mean age 55.9 ± 13.7 years, range 32-82) with descending thoracic aortic dissection. Indications for stent-graft implantation were persistent symptoms unresponsive to medical treatment or progressive enlargement of the false lumen. Clinical and imaging surveillance with computed tomography was performed within 1 month of the procedure and at 3 to 6-month intervals in follow-up. Results: Endovascular stent-graft implantation at the target site was successful in 14 (93%) patients; 1 device migrated, leaving the false lumen open to flow in the failed case. One (7%) patient who was treated emergently for rupture died suddenly 2 days after the procedure. Over an average follow-up of 31.5 ± 23.8 months, 1 (7%) patient died and 2 (14%) patients underwent surgical treatment due to recurrent dissection. The remaining 10 patients showed complete thrombosis of the false lumen; in 3, the false lumen completely resolved. Conclusions: Endovascular stent-graft implantation in descending thoracic aortic dissection is a feasible, safe, and effective treatment modality. However, further studies are necessary in a greater number of patients to determine if wider application of this minimally invasive procedure is justified.
UR - http://www.scopus.com/inward/record.url?scp=0345074149&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0345074149&partnerID=8YFLogxK
U2 - 10.1583/1545-1550(2002)009<0817:TOTADW>2.0.CO;2
DO - 10.1583/1545-1550(2002)009<0817:TOTADW>2.0.CO;2
M3 - Article
C2 - 12546583
AN - SCOPUS:0345074149
SN - 1526-6028
VL - 9
SP - 817
EP - 821
JO - Journal of Endovascular Therapy
JF - Journal of Endovascular Therapy
IS - 6
ER -